TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Oncology

Sentinel lymph node mapping in the modern management of gynaecological malignancy

Key Statistics

  • <5% — Target false negative rate, SLN mapping
  • 25.2% → 1.9% — Lymphoedema: Lymphadenectomy vs SLN (vulval)
  • 100% — ICG+Tc99 detection rate, endometrial cancer

Don't-miss facts

  1. Target false negative rate for any SLN technique: <5%

  2. SLN intraoperative definition: count ratio ≥10:1 vs background; residual basin activity should be <10% of SLN count

  3. Blue dye visible window 10–30 min, gone by ~50 min; Tc-99m best detected 1–6 h post-injection (give pre-op)

  4. ICG: avoid in iodine allergy/liver dysfunction; contains 5% sodium iodide

  5. Vulval SLN standard of care: unifocal, <4 cm, no suspicious groin nodes; midline tumours (≤1 cm) need bilateral detection or side-specific lymphadenectomy

  6. Frozen section NOT recommended in cervical (SENTIX) or endometrial (SENTOR/SENTI-ENDO) cancer – poor sensitivity

  7. GROINSS-V II: any positive SLN needs further groin treatment; macrometastasis → lymphadenectomy; micrometastasis → radiotherapy is a safe alternative

  8. Ultrastaging (serial sectioning + AE1-AE3 IHC) mandatory for SLN processing – detects micrometastases/ITC invisible on standard H&E

Detection rate ranking (best tracer combo)

Endometrial: ICG+Tc-99m 100%, sensitivity 100%, FN 0% Cervical: ICG 98% Vulval: Tc-99m+blue dye 98%

Abbreviation Key

  • SLN — sentinel lymph node
  • LVSI — lymphovascular space invasion
  • ICG — indocyanine green
  • SCC — squamous cell carcinoma
  • Tc99/Tc-99m — technetium-99m radiolabelled colloid
  • FIGO — International Federation of Gynecology and Obstetrics
  • NIR — near infrared
  • EBRT — external beam radiotherapy
  • SPECT-CT — single-photon emission computed tomography–CT
  • HR — hazard ratio
  • ITC — isolated tumour cell (<0.2 mm deposit)
  • RCT — randomised controlled trial
  • H&E — haematoxylin and eosin stain
  • GOG — Gynecologic Oncology Group
  • NPV — negative predictive value
  • MSKCC — Memorial Sloan Kettering Cancer Centre

Source: Collins A, Phillips A. Sentinel lymph node mapping in the modern management of gynaecological malignancy. The Obstetrician & Gynaecologist 2023;25:210–219. doi:10.1111/tog.12872

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free